Litcius/Paper detail

Visceral obesity and muscle mass determined by CT scan and surgical outcome in patients with advanced ovarian cancer. A retrospective cohort study

Colin Heus, Andre Smorenburg, Jaap Stoker, Marianne J. Rutten, Frédéric Amant, Luc R.C.W. van Lonkhuijzen

2020Gynecologic Oncology33 citationsDOIOpen Access PDF

Abstract

OBJECTIVE: Visceral obesity (VO) is a risk factor for developing postoperative complications in patients undergoing abdominal oncological surgery. However, in ovarian cancer patients this influence of body composition on postoperative morbidity is not well established. The aim of this study is to assess the association between body composition and complications in patients with advanced ovarian cancer undergoing cytoreductive surgery. METHODS: . The perioperative data were extracted retrospectively. A multivariate logistic regression analysis was performed to test the predictive value of multiple variables such as body composition, albumin levels and preoperative morbidity. RESULTS: 298 consecutive patients out of nine referring hospitals were included. VO patients were more likely to be hypertensive (38% vs 17% p < 0.001), and to have an ASA 3 score (21% vs 10% P = 0.012). Complications occurred more often in VO patients (43% vs 21% P < 0.001). Thrombotic events were found in 4.9% of VO patients versus 0.6% of the non-visceral obese patients (p = 0.019). VO(OR: 4.37, p < 0.001), hypertension (OR:1.9, p = 0.046) and duration of surgery (OR: 1.004, p = 0.017) were predictors of post-surgical complications. Muscle mass is not a predictor of complications. CONCLUSION: Visceral obesity is associated with a higher occurrence of complications in patients with advanced ovarian cancer undergoing cytoreductive surgery.

Topics & Concepts

MedicinePerioperativeRetrospective cohort studyOvarian cancerLogistic regressionInternal medicineBody mass indexObesityCancerStage (stratigraphy)CohortSurgeryGastroenterologyBiologyPaleontologyNutrition and Health in AgingCancer Risks and FactorsEndometrial and Cervical Cancer Treatments